ライフサイエンスコーパス: mononucleosis

1 13 patients presenting with sore throat has mononucleosis).

2 , defined as flu-like symptoms or infectious mononucleosis).

3 D4(+) and CD8(+) T cells in acute infectious mononucleosis.

4 t of uncomplicated or complicated infectious mononucleosis.

5 uent establishment of latency and infectious mononucleosis.

6 and Mig protein than tissues with infectious mononucleosis.

7 lization, and office diagnosis of infectious mononucleosis.

8 s associated with an increased likelihood of mononucleosis.

9 c symptoms, or have self-limiting infectious mononucleosis.

10 y, specificity, and LRs for the diagnosis of mononucleosis.

11 limit EBV replication and prevent infectious mononucleosis.

12 D25 is absolutely required for CD8(+) T cell mononucleosis.

13 om are seen only in patients with infectious mononucleosis.

14 ith the incidence and severity of infectious mononucleosis.

15 irologic evaluations during acute infectious mononucleosis.

16 mmaglobulenemia without an episode of severe mononucleosis.

17 s reported in patients with acute infectious mononucleosis.

18 Of these, 77% had infectious mononucleosis, 12% had atypical symptoms, and 11% were a

19 ct size=1.5 x 10(-19); I(2)=43%), infectious mononucleosis (2.17, 1.97-2.39; p=3.1 x 10(-50); I(2)=0%

20 osis, and Epstein-Barr virus/cytomegalovirus/mononucleosis, 30% to 60% of circulating CD8 T cells had

21 ssociated with HIV (28%, 33%) and infectious mononucleosis (33%).

22 rus (EBV), the causative agent of infectious mononucleosis, a self-limiting lymphoproliferative disea

23 ype manifested by severe or fatal infectious mononucleosis, acquired hypogammaglobulinemia and malign

24 atients with EBV invariably results in fatal mononucleosis, agammaglobulinemia, or malignant lymphoma

25 from Chinese children with acute infectious mononucleosis (AIM) and chronic active EBV infection (CA

26 0 individuals followed from acute infectious mononucleosis (AIM) into convalescence (CONV).

27 ecimens was not observed in acute infectious mononucleosis (AIM) patients.

28 cing primary EBV infection (acute infectious mononucleosis [AIM]) and again 6 months later (during co

29 ptomatic primary infection (acute infectious mononucleosis [AIM]).

30 least a year after resolution of infectious mononucleosis, although the clone size is reduced.

31 nt in 66% of patients (12/20 with infectious mononucleosis and 12/16 with tonsillar hyperplasia).

32 m 20 American children with acute infectious mononucleosis and 16 Swiss children with chronic tonsill

33 Though it is associated with infectious mononucleosis and approximately 200,000 cancers annually

34 Epstein-Barr virus (EBV) causes infectious mononucleosis and can lead to lymphoproliferative diseas

35 e infections that result in acute infectious mononucleosis and chronic infections that result in lymp

36 ated with prolonged fatigue after infectious mononucleosis and contrast these factors with those that

37 tected at presentation with acute infectious mononucleosis and declined rapidly thereafter.

38 ggest a role for these analogous proteins in mononucleosis and have implications for their use as vac

39 r virus is the causative agent of infectious mononucleosis and infects approximately 90% of the world

40 Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with cancers in immunoco

41 EBV causes infectious mononucleosis and is associated with certain malignancie

42 svirus, is the causative agent of infectious mononucleosis and is associated with many carcinomas.

43 s (EBV) is the causative agent of infectious mononucleosis and is associated with several forms of ca

44 The ubiquitous EBV causes infectious mononucleosis and is associated with several types of ca

45 s a human herpesvirus that causes infectious mononucleosis and is associated with several types of ca

46 (EBV) is the most common cause of infectious mononucleosis and is associated with the development of

47 ous human herpesvirus that causes infectious mononucleosis and is etiologically associated with malig

48 surveillance, nevertheless causes infectious mononucleosis and is strongly linked to several types of

49 es numerous health risks, such as infectious mononucleosis and lymphoproliferative disorder.

50 s a human herpesvirus that causes infectious mononucleosis and lymphoproliferative malignancies.

51 rus EBV, which is associated with infectious mononucleosis and malignant tumors, harbors many immune-

52 en adolescents with CFS following infectious mononucleosis and recovered controls.

53 itous herpesvirus associated with infectious mononucleosis and several tumors.

54 However, the transient mononucleosis and spike in latently infected cells assoc

55 el variants are frequent in acute infectious mononucleosis and tonsillar hyperplasia and identical to

56 onors with acute gastroenteritis, infectious mononucleosis, and Epstein-Barr virus/cytomegalovirus/mo

57 EBV vaccine might help to prevent infectious mononucleosis, and further development of this should no

58 A history of infectious mononucleosis, and high baseline EBV antibody titers are

59 ction is the most common cause of infectious mononucleosis, and persistent infection is associated wi

60 s (anti-EBNA IgG seropositivity), infectious mononucleosis, and smoking showed the strongest consiste

61 diagnosed with acute EBV-induced infectious mononucleosis, as assessed by semiquantitative RT-PCR an

62 anifestations include fatal acute infectious mononucleosis, B-cell lymphoma, and progressive dys-gamm

63 isease who were misdiagnosed with infectious mononucleosis based on false-positive tests for primary

64 up to 5% of the CD8(+) T cells in infectious mononucleosis blood, the strongest latent Ag-specific re

65 Early, accurate diagnosis of infectious mononucleosis can help clinicians target treatment, avoi

66 Infectious mononucleosis caused by Epstein-Barr virus (EBV) usually

67 id tissues with acute EBV-induced infectious mononucleosis compared to tissues with PTLD and raise th

68 19-year-old female who developed infectious mononucleosis complicated by unilateral empyema.

69 olescents who have recovered from infectious mononucleosis (controls), while certain cytokine network

70 interactions during self-limited infectious mononucleosis could explain how Epstein-Barr virus (EBV)

71 When fulminant infectious mononucleosis (FIM) was excluded, there was no statistic

72 patients often develop fulminant infectious mononucleosis (FIM), a life-threatening condition marked

73 its clinical presentation: fatal infectious mononucleosis (FIM), lymphomas, and immunoglobulin defic

74 in the clinical syndrome of acute infectious mononucleosis (glandular fever).

75 cal sequelae, including fulminant infectious mononucleosis, hemophagocytic lymphohistiocytosis, lymph

76 substantial genetic component in infectious mononucleosis (IM) etiology.

77 Infectious mononucleosis (IM) is an immunopathological disease caus

78 Acute infectious mononucleosis (IM) is associated with altered expression

79 nfrequently, EBV infection causes infectious mononucleosis (IM) or Burkitt lymphoma (BL).

80 e nonswitched memory pool both in infectious mononucleosis (IM) patients undergoing primary infection

81 ose found in healthy individuals, infectious mononucleosis (IM) patients, and 12 PTLD patients bled a

82 nses that, by T cell cloning from infectious mononucleosis (IM) patients, appear skewed toward immedi

83 has suggested that patients with infectious mononucleosis (IM) who are undergoing primary Epstein-Ba

84 Analysis of infectious mononucleosis (IM), a clinical syndrome that can arise d

85 arr virus (EBV) and occurrence of infectious mononucleosis (IM), a cross-sectional study was undertak

86 rus (EBV), the causative agent of infectious mononucleosis (IM), a disease associated with large viru

87 tion later in life often leads to infectious mononucleosis (IM), a febrile illness characterized by a

88 ayed infection is associated with infectious mononucleosis (IM), a febrile illness in which patients

89 on in adolescence can manifest as infectious mononucleosis (IM), as a fatal illness that magnifies th

90 s pathognomonic of EBV-associated infectious mononucleosis (IM), common in young adults.

91 tissues from patients with acute infectious mononucleosis (IM), interfollicular immunoblasts were sh

92 e, which seems identical to human infectious mononucleosis (IM), persists for a further month or more

93 included 8 cases of uncomplicated infectious mononucleosis (IM).

94 induces a syndrome comparable to infectious mononucleosis (IM).

95 stein-Barr virus (EBV)-associated infectious mononucleosis (IM).

96 ipheral blood of 13 subjects with infectious mononucleosis (IM).

97 lls (PBMCs) from 26 patients with infectious mononucleosis (IM).

98 isted of the clinical syndrome of infectious mononucleosis in 7 children; in addition, 10 children de

99 We present a paediatric case of infectious mononucleosis in a 13-year old, manifesting with follicu

100 s in many respects to EBV-induced infectious mononucleosis in humans.

101 Mononucleosis is most commonly present among patients ag

102 tivities support the concept that infectious mononucleosis is most likely acquired by kissing.

103 The likelihood of mononucleosis is reduced with the absence of any lymphad

104 Infectious mononucleosis is the clinical manifestation of primary i

105 rus (EBV), the causative agent of infectious mononucleosis, is a human herpesvirus associated with ep

106 exhibits a reduction in the development of a mononucleosis-like disease in mice, and can protect mice

107 , primary infection with HHV-6 can produce a mononucleosis-like illness and, more rarely, severe dise

108 y of CD4+CD25+ T regulatory cells during the mononucleosis-like phase of this viral infection.

109 even days later, he presented with a febrile mononucleosis-like syndrome associated with dramatic shi

110 Development of an infectious mononucleosis-like syndrome correlates with the establis

111 latency or the development of the infectious mononucleosis-like syndrome in infected mice.

112 th groups developed the prominent infectious mononucleosis-like syndrome that is characteristic of th

113 ere was no PTLD and one case of EBV disease (mononucleosis-like syndrome), which resolved.

114 Like EBV-infected humans with infectious mononucleosis, mice infected with the rodent gammaherpes

115 including chickenpox, shingles, cold sores, mononucleosis, mumps, hepatitis B, plantar warts, positi

116 serum or plasma has been found in infectious mononucleosis, nasopharyngeal carcinoma, posttransplant

117 s involved in determining whether infectious mononucleosis occurs after primary EBV infection may inc

118 These focus on: (i) patients with infectious mononucleosis or its fatal equivalent, X-linked lymphopr

119 of 250 primary-care patients with infectious mononucleosis or ordinary upper-respiratory-tract infect

120 d B cells, isolated from the same infectious mononucleosis patients, to determine whether differences

121 man lymphocryptovirus that causes infectious mononucleosis, persists asymptomatically for life in nea

122 exhibited the characteristic postinfectious mononucleosis phenotype of XLP with hypogammaglobulinemi

123 that indicates that a history of infectious mononucleosis predisposes to HL.

124 persistent infection, along with infectious mononucleosis, providing a model for studying these proc

125 Three presented with EBV infectious mononucleosis requiring hospitalization, 1 had chronic a

126 ned from donors with a history of infectious mononucleosis, showed diminished survival in culture wit

127 ms are of limited value for the diagnosis of mononucleosis; sore throat and fatigue are sensitive (ra

128 is significantly increases the likelihood of mononucleosis (summary LR, 11.4 [95% CI, 2.7-35] for aty

129 mary infections, including 2 with infectious mononucleosis syndrome.

130 mola and Kaarianinen (3) first described CMV mononucleosis, the principal presentation of previously

131 iteria for CFS 6 months following infectious mononucleosis; the figure was 7% at 12 months and 4% at

132 to nasopharyngeal carcinoma, from infectious mononucleosis to Hodgkin's disease (HD) and Burkitt's ly

133 ge from the fairly benign disease infectious mononucleosis to life-threatening cancer.

134 from asymptomatic viremia through infectious mononucleosis to posttransplant lymphoproliferative diso

135 A history of infectious mononucleosis was negatively associated with NHL risk (O

136 eran-reported physician-diagnosed infectious mononucleosis were associated with CMI among deployed ve

137 hat the majority of patients with infectious mononucleosis were infected with multiple strains of EBV

138 Unlike acute infectious mononucleosis, wherein EBV establishes lifelong infectio